NT-3 Levels and Function in Individuals With CMT

NCT05011006 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2025-06-24

No results posted yet for this study

Summary

This study will assess the serum NT-3 levels in individuals with the diagnosis of peripheral neuropathy or any type of Charcot-Marie-Tooth Neuropathy (CMT) and correlate this with function.

Conditions

Interventions

DIAGNOSTIC_TEST

NT3 blood draw

blood draw

Sponsors & Collaborators

  • Zarife Sahenk

    lead OTHER

Principal Investigators

  • Zarife Sahenk, MD., PhD. · Nationwide Children's Hospital

Eligibility

Min Age
7 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2027-11-13
Primary Completion
2030-06-30
Completion
2030-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05011006 on ClinicalTrials.gov